Scienture Holdings, Inc.

SCNX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Sep 2025 Mar 2025 Sep 2024 Jun 2024 Dec 2023 Sep 2023
Revenue $343.6K $56.3K $590.1K $10.3K $64.9K $18.7K $111.7K $392.3K
Cost of Revenue $7.9K $2.5K $15.4K $9.6K $61.0K $19.4K $-334.9K $352.7K
Gross Profit $335.8K $53.9K $574.6K $673 $3.9K $-703 $-130.9K $39.6K
Gross Margin 97.7% 95.6% 97.4% 6.6% 6.0% -3.8% -117.2% 10.1%
Operating Expenses
Research & Development $1.2M $794.0K $169.3K $574.7K $1.3M — — —
SG&A Expense $368.8K $1.1M $2.2M $1.4M $168.6K $415.4K $851.8K $66.9K
Operating Income $-2.7M $-3.5M $-4.4M $-3.6M $-3.5M $-1.5M $-2.2M $-761.7K
Operating Margin -785.6% -6,230.8% -739.1% -34,814.9% -5,392.7% -7,998.8% -1,995.4% -194.2%
Interest Expense — — — — — — $703.4K $251.8K
Pretax Income — — $-3.6M $-3.1M $-3.2M $-1.6M — —
Income Tax Expense — — — — — — — —
Net Income $-2.8M $-3.4M $-3.6M $-3.1M $-3.2M $-1.8M $-11.7M $-3.5M
Net Margin -821.3% -6,040.4% -611.4% -29,869.3% -4,908.3% -9,807.5% -10,443.5% -898.6%
EPS (Basic) $-0.07 $-0.08 $-0.05 $-0.08 $-0.34 $-0.33 $-3.72 $-0.29
EPS (Diluted) $-0.07 $-0.08 $-0.05 $-0.08 $-0.34 $-0.33 $-3.72 $-0.29
Shares Outstanding (Basic) 39.6M 40.6M 75.8M 37.7M 9.5M 5.6M 3.1M 12.3M
Shares Outstanding (Diluted) 39.6M 40.6M 75.8M 37.7M 9.5M 5.6M 9.5M 37.8M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 6 Older →